DAILY UPDATE: Novartis AG Up, Verizon Down as Markets Surge

By Staff Reporters

***

***

(Bloomberg) — Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in shares as it prepares to spin off its Sandoz generics unit.  Operating profit excluding some items will likely grow by low double digits this year, the Swiss drug maker said in a statement, raising its forecast for a second time from a prior estimate of high single-digits gains. The stock rose as much as 4% in Zurich trading. 

CITE: https://www.r2library.com/Resource

***

Shares of U.S. telecom giant Verizon (NYSE: VZ) fell 7.5% in trading on Monday after a series of articles in The Wall Street Journal highlighted the lead in cable sheathing that telecom companies used decades ago. Some analysts downgraded the stock, but the market sold before more details were available from the company. 

***

Here is where the major market benchmarks ended:

U.S. stocks extended a rally as better-than-expected bank results boosted the S&P 500 and NASDAQ to fresh 15-month highs.

  • The S&P 500 Index was up 32.19 points (0.7%) at 4,554.98; the Dow Jones industrial average was up 366.58 points (1.1%) at 34,951.93; the NASDAQ Composite was up 108.69 points (0.8%) at 14,353.64.
  • The 10-year Treasury note yield (TNX) was little changed at 3.793%.
  • CBOE’s Volatility Index (VIX) was down 0.16 at 13.32.

Financial stocks were among the strongest performers Tuesday, sending the KBW Regional Banking Index (KRX) up over 4%. Oilfield services shares were also strong as crude oil futures gained over 2%. The small-cap Russell 2000 (RUT) gained over 1% and posted a five-month high.

***

ORDER: https://www.routledge.com/Risk-Management-Liability-Insurance-and-Asset-Protection-Strategies-for/Marcinko-Hetico/p/book/9781498725989

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

COMMENTS APPRECIATED

Thank You

***

PODCAST: Novartis Drug Company Settlement with the USA

Why SOME Doctors Take Money from Pharmaceutical Companies

Q&A: Eric Bricker, chief medical officer of Compass patient advocacy service - Dallas Business ...

BY ERIC BRICKER MD

MAssive Global Drug Company Novartis Paid $678M to Settle Charges from the US Federal Government.

The Charges Were Regarding Illegal Payments and Kickbacks to Doctors that Were Thinly-Veiled as ‘Speaker Fees’ and Fancy Dinners.

Why Where the Doctors Not Held Accountable and What Does This Say About a Doctor’s Mentality on Money?

Learn the Psychology of Doctors and Money.

Understand How It Leads to Counterproductive Relationships Between Physicians and Drug Companies, Which Can Compromise the #1 Rule in Medicine: The Patient Comes First, Always.

Disclaimer: Dr. Bricker is the Chief Medical Officer of Virtual Care Company First Stop Health

YOUR THOUGHTS ARE APPRECIATED

Thank You

***